CoChat

Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems

Lu, Mei, Li, Jia, Haller, Irina V., Romanelli, Robert J., VanWormer, Jeffrey J., Rodriguez, Carla V., Raebel, Marsha A., Boscarino, Joseph A., Schmidt, Mark A., Daida, Yihe G., Sahota, Amandeep, Vincent, Jennifer, Bowlus, Christopher L., Lindor, Keith, Rupp, Loralee B., Gordon, Stuart C., Everline, Rene, Daar, Zahra S., Melkonian, Christina, Zhang, Talan, Zhou, Yueren, Wu, Hank, Larkin, Dana, Islam, Nishat, Akkerman, Nonna, Trudeau, Sheri, Kohnhorst, Diane, Shaw, Sally F., Chiu, Vicki, Donald, Judy, Turner, Michelle, Rubenstein, Kevin, Redd, Jacquelyn, Wong, Carmen, Mor, Joanne, Bow, Kathy, Pieper, Lisa E., Anderson, Heather, Tesch, Nathan, Trimble, Solomon, De Los Santos, Mario J., Amlin, Tina, Khan, Shamyal, Dunlap, Kevin · 2018 · Clinical Gastroenterology and Hepatology
Cited by 83

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

BACKGROUND & AIMS Reported prevalence of primary biliary cholangitis (PBC) varies widely. Demographic features and treatment patterns are not well characterized in the United States (US). We analyzed data from the Fibrotic Liver Disease (FOLD) Consortium, drawn from 11 geographically diverse health systems, to investigate epidemiologic factors and treatment of PBC in the US. METHODS We developed a validated electronic health record‐based classification model to identify patients with PBC in the FOLD database from 2003 through 2014. We used multivariable modeling to assess the effects of factors associated with PBC prevalence and treatment with ursodeoxycholic acid (UDCA). RESULTS We identified 4241 PBC cases among over 14.5 million patients in FOLD health systems; median follow‐up was 5 years. Accuracy of the classification model was excellent, with an area under the receiver operating characteristic curve value of 93%, 94% sensitivity, and 87% specificity. The average patient age at diagnosis was 60 years; 21% were Hispanic, 8% were African American, and 7% were Asian American/American Indian/Pacific Islander. Half of the cohort (49%) had elevated levels of alkaline phosphatase, and overall, 70% were treated with UDCA. The estimated 12‐year prevalence of PBC was 29.3 per 100,000 persons. Adjusted prevalence values were highest among women (42.8 per 100,000), White patients (29.6 per 100,000), and patients 60–70 years old (44.7 per 100,000). Prevalence was significantly lower among men and African Americans (10.7 and 19.7 per 100,000, respectively) than women and whites; men and African Americans were also less likely to receive UDCA treatment (odds ratios, 0.6 and 0.5, respectively; P < .05). CONCLUSIONS In an analysis of a large cohort of patients with PBC receiving routine clinical care, we observed significant differences in PBC prevalence and treatment by gender, race, and age.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cgh.2017.10.018

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 83

Metadata

Authors
Lu, M., Li, J., Haller, I. V., Romanelli, R. J., VanWormer, J. J., Rodriguez, C. V., Raebel, M. A., Boscarino, J. A., Schmidt, M. A., Daida, Y. G., Sahota, A., Vincent, J., Bowlus, C. L., Lindor, K., Rupp, L. B., Gordon, S. C., Everline, R., Daar, Z. S., Melkonian, C., Zhang, T., Zhou, Y., Wu, H., Larkin, D., Islam, N., Akkerman, N., Trudeau, S., Kohnhorst, D., Shaw, S. F., Chiu, V., Donald, J., Turner, M., Rubenstein, K., Redd, J., Wong, C., Mor, J., Bow, K., Pieper, L. E., Anderson, H., Tesch, N., Trimble, S., De Los Santos, M. J., Amlin, T., Khan, S., & Dunlap, K.
Venue
Clinical Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2018-08
Volume
16
Issue
8
Pages
1333-1341.e6
ISSN
1542-3565 (ISSN-L)
OpenAlex
W2766912018
Cited by
83
References
9
FWCI
3.08
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.